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Abstract The gene expression profile of the HIV-1 infection
state was analyzed in the human T cell line MOLT-4. Using the
serial analysis of gene expression (SAGE) method, a total of
142 603 SAGE tags were sequenced and identified, representing
43 581 unique mRNA species. Comparison of expression patterns
revealed that 53 cellular genes were differentially expressed upon
HIV-1 infection. Northern blot and RT-PCR analyses confirmed
the altered expression of the genes in both MOLT-4 and MT-4
cells. Up-regulated genes were mainly composed of transcription
factors and genes related to T cell activation, whereas down-
regulated genes were comprised of mitochondrial proteins, actin-
related factors and translational factors. These findings indicate
that persistent T cell activation, which may accelerate HIV-1
replication, and the disruption of cellular housekeeping genes
including those involved in anti-apoptotic systems, may play an
important role in HIV-1-induced pathogenesis.
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1. Introduction
Human immunode¢ciency virus type 1 (HIV-1) infection is
composed of a host-parasite relationship in which virus uti-
lizes the host cell’s macromolecular machinery and energy
supplies to produce progeny virus [1]. Inevitably, HIV-1 in-
fection alters cellular physiological states leading to disturb-
ance of immune responses, cell growth arrest, and cell death,
where certain gene activities are considered to be crucial [2].
Studies on HIV-1 pathogenesis have recently been expanded
to de¢ne the changes in gene expression occurring in infected
cells in association with HIV-1 replication and apoptosis [3^
5]. However, most of these studies have focused on only a
limited number of biological parameters, even though the
phenomena were clearly a part of a more complex network
of related factors. To further understand the cellular events
and the pathogenesis occurring after HIV-1 infection, it is
essential to survey an overall di¡erential gene expression pat-
tern.
Herein, we used the serial analysis of gene expression
(SAGE) method [6] to systematically analyze gene expression
pro¢les in HIV-1-infected T cells. SAGE allows the simulta-
neous quantitative analysis of a large number of transcripts in
cells or tissues without prior knowledge of genes [6^8]. For
SAGE analysis, we used the human T cell line MOLT-4.
MOLT-4 cells are well characterized and susceptible to
HIV-1 infection [10], and can be maintained without any stim-
ulation needed to facilitate HIV infection by agents such as
phytohemagglutinin or anti-CD3 antibody, which may in£u-
ence cellular gene expression [11]. We obtained a total of
142 603 SAGE tags and newly identi¢ed 53 cellular genes
up- or down-regulated upon HIV-1 infection.
2. Materials and methods
2.1. Cell culture and HIV-1 infection
MOLT-4 and MT-4 cells were maintained at 37‡C in RPMI 1640
medium supplemented with 10% fetal calf serum (FCS). A total of
1U106 viable cells were mixed with 105 50% tissue culture infectious
dose (TCID50) of HIV-1NL4ÿ3 and incubated for 2 h at 37‡C [9]. Cells
were washed twice with and resuspended in complete medium to
2.5U105 cells/ml. MOLT-4 cells were harvested at 96 h after infection
in which HIV-1 antigen-positive cells were 53% of the total cells, the
viability of cells was 92^95% and speci¢c cytopathic e¡ects were ob-
served [10].
2.2. SAGE analysis
SAGE libraries were generated using 30 Wg of total RNA from
HIV-1NL4ÿ3- and mock-infected MOLT-4 cells as described previously
[6], except that restriction enzymes RsaI and BsmFI were used as
anchoring and tagging enzyme, respectively [12]. The concatemerized
sequence tags were cloned into dephosphorylated pUC118 vectors.
Recombinant plasmid DNAs were sequenced with Big Dye terminator
kits (PE Applied Biosystems) using an ABI 377XL automated se-
quencer (PE Applied Biosystems). PROGENEX software (Fujiyaku-
hin Co., Saitama, Japan) was applied to extract and analyze SAGE
tags [12]. The representative tag sequences were compared for homol-
ogy against databases as described previously [13].
2.3. Northern blot analysis
Eight micrograms of total RNA was separated on a 1.5% agarose
gel containing 0.66 M formaldehyde and transferred to a Duralon-UV
membrane (Stratagene, La Jolla, CA, USA). The ¢lters were baked at
80‡C for 2 h. The cDNAs of V300 bp were ampli¢ed with RT-PCR
and labeled with [32P]dCTP using a DNA labeling kit (Nippon Gene).
Membrane ¢lters were hybridized with labeled probes (1U106 cpm/
ml) in the bu¡er (40% deionized formamide, 4USSC, 10% Dextran
sulfate, 1UDenhardt’s solution, 40 Wg/ml sonicated and denatured
salmon sperm DNA, 0.1% SDS, 20 mM Tris (pH 7.5)) at 42‡C for
16 h. The ¢lters were washed twice for 15 min at room temperature
and once for 30 min at 56‡C with 2USSC containing 0.1% SDS, and
exposed using a Fuji Imaging Plate [13]. Densitometric analysis was
performed using a BAS2000 system (Fuji Photo Co., Tokyo, Japan).
2.4. Kinetics of infection.
Mock- and HIV-1NL4ÿ3-infected MT-4 cells were harvested at sev-
eral time points for 96 h post-infection (p.i.) (see Fig. 2). Viable cells
were counted by the trypan blue dye exclusion method. Virus produc-
tion in culture supernatant from HIV-1-infected cells was monitored
by an enzyme-linked immunosorbent assay (ELISA) speci¢c to the
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HIV-1 p24-gag antigen (Coulter, Hialeah, FL, USA) according to the
manufacturer’s instruction.
3. Results
3.1. SAGE analysis
A summary of transcript abundance and corresponding
gene representation is provided in Table 1. Among 142 609
transcripts representing 43 581 unique genes, approximately
half were derived from the population of HIV-1- and mock-
infected MOLT-4 cells.
Comparison of the two SAGE pro¢les indicated that the
great majority of genes were expressed at similar levels irre-
spective of virus infection. However, approximately 200 genes
were expressed at signi¢cantly di¡erent levels (by ¢ve-fold or
more) in HIV-1-infected MOLT-4 cells. Of these di¡erentially
expressed genes, we selected 57 sequence tags that matched
known genes and EST entries. Among the up-regulated genes,
the four that only appeared in the HIV-1-infected cell pro¢le
represented HIV-1 transcripts (Table 2). The remaining 22
genes up-regulated upon HIV-1 infection were arbitrarily sub-
divided into four groups (Table 2): (1) genes related to cell
activation and signaling pathways, (2) transcription factors,
(3) interferon-induced genes and (4) miscellaneous genes.
Likewise, 31 down-regulated genes were classi¢ed into four
groups (Table 3): (1) mitochondrial proteins and antioxidants,
(2) actin-related factors, (3) translational factors and (4) mis-
cellaneous genes. Overall, the up-regulated genes were mainly
comprised of genes that accelerated HIV-1 replication, where-
as down-regulated genes were involved in anti-apoptotic cell
defense and regulation of basic cellular functions.
To test the reliability of SAGE results, we examined the
expression of 10 arbitrarily selected genes by Northern blot
Fig. 1. Northern blot analysis of genes di¡erentially expressed in
HIV-1NL4ÿ3-infected MOLT-4 cells. HIV-LTR, HIV-1 long terminal
repeat; MAPKK3, mitogen-activated protein kinase kinase 3; AS,
argininosuccinate synthetase; ETR101, transcriptional factor
ETR101; BTAg, breast tumor autoantigen; CRHP, cysteine-rich
heart protein; eIF4AI, eukaryotic initiation factor 4AI; NOP56,
nucleolar protein NOP56; TSA, thiol-speci¢c antioxidant; EtBr,
ethidium bromide.
Fig. 2. A: Kinetics of virus replication (p24gag antigen in culture £uid) (upper) and apoptosis levels (lower) in HIV-1NL4ÿ3-infected MT-4 cells.
P24gag antigen in culture £uid was measured by an ELISA speci¢c for the HIV-1 p24gag antigen (Coulter, Hialeah, FL, USA). Degree of apop-
tosis was analyzed using propidium iodide staining and £ow cytometry. B: Kinetics of mRNA levels of selected genes in HIV-1NL4ÿ3-infected
MT-4 cells. Cells were collected at 24, 48, 60, 72 h after infection. Signals were quantitated densitometrically normalized to ribosomal protein
L32, and expressed relative to the signals in the uninfected cells. Gene descriptions were the same as in Fig. 1.
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analysis. The results of Northern analysis substantiate the
di¡erential expression of the genes in infected MOLT-4 cells
(Fig. 1). RT-PCR also con¢rmed signi¢cant di¡erences in the
expression of whole genes in Tables 2 and 3 between the
samples (data not shown).
3.2. Kinetics of mRNA expression associated with virus
replication and apoptosis
To address whether the genes detected in the MOLT-4 cell
line are also dysregulated in other CD4 T cell lines, and to
investigate the kinetics of these changes, we arbitrarily se-
lected four genes and performed Northern blot analysis using
MT-4 cells. Kinetic study showed that almost all MT-4 cells
were infected with HIV-1 within a few days followed by severe
apoptotic cell death and extremely high levels of virus repli-
cation (Fig. 2A). Northern blot analysis revealed that the ex-
pression levels of nucleolar protein NOP56 and eukaryotic
initiation factor (eIF)-4AI gradually decreased during the
process of infection, while those of argininosuccinate synthe-
tase (AS) and mitogen-activated protein kinase kinase 3
(MAPKK3) increased rapidly at 72 h post-infection (Fig.
2B). These results indicate that the altered expression of the
genes identi¢ed by SAGE was closely correlated with the time
course of viral replication and apoptosis. This con¢rms the
validity and feasibility of the present study.
4. Discussion
4.1. Genes related to the HIV-1 replication signals are
overexpressed
Consistent with the notion that HIV-1 deregulates genes
involved in HIV replication [14], a number of genes encoding
accelerators for viral and cell growth are stimulated in HIV-1-
infected T cells. We grouped these genes into ¢ve groups.
The ¢rst group includes genes linked to cell activation and
related genes involved in signaling pathways. Peripheral blood
micronuclear cells from asymptomatic patients showed a sig-
ni¢cantly increased level of tumor necrosis factor K (TNF-K)-
receptor-positive cells compared with controls, although this
was not the case in AIDS patients [15]. Several reports also
Table 2
Up-regulated genes in HIV-1-infected T cells
SAGE tag Gene description Accession number H/Ma
0. HIV transcripts
TGGGTCTCTCTGGT HIV-1 transcript Z11530 92/0
CTGAGGTGTGACTG HIV-1 transcript Z11530 9/0
CGTCAGCGTCATTG HIV-1 transcript Z11530 9/0
CCACAGACCCCAAC HIV-1 transcript Z11530 7/0
1. Cell activation and signaling pathway
CAGCAGGCAGAGCC Mitogen-activated protein kinase kinase 3 (MAPKK3) D87116 37/7
TCAGGAGGCTGAGG Tumor necrosis factor receptor 75 kDa S63368 35/7
AGGCGCTAATTGTT Argininosuccinate synthetase (AS) X01630 15/0
TGTGGGCTGTGCTG Transcription factor ETR101 M62831 13/1
CAGAGGATGGTGAG Fibroblast growth factor receptor (FGFR) M60485 12/1
GCACCCGCTGGGCA Lymphocyte activation antigen 4F2 large subunit J03569 9/1
TAGCTGTGTGTTCT Ca channel B3 subunit (CAL Bet 3) L27584 6/0
AGACGGTGTGGGGG Leukosialin (CD43) M61827 5/0
2. Transcription factors
TGAGACAGGGTGCT Helix-loop-helix zipper protein M77476 21/4
CAGGGCCATGCAGG Basic leucine zipper transcription factor MafG U84249 11/1
TGAGATGTGGCTGG Zinc ¢nger protein (ZNF139) U09848 6/0
CCCTCTGACCCACC Ets domain protein ERF U15655 5/0
AGCTCCGGACTCTT GATA-3 enhancer binding protein M69106 5/0
3. IFN-induced genes
GGCCTCAAGCCCCT Interferon-induced 17/15 kDa protein M13755 33/6
CAGGGCAAGAAGCC Interferon-inducible protein (IP-30) J03909 12/1
AATGCTGCTGCCTT Putative interferon-related protein (SM15) U09585 6/0
4. Miscellaneous genes
CAGTGTGTGTTGAT EST 1 W86328 20/2
TGTCCATCTGCCTG Rapamycin and FK506 binding protein M75099 10/0
AGCCCCAGATGGGA HIV-1 promoter region chimeric mRNA U19178 5/0
CCTGTGTTTTACCT Breast tumor autoantigen U24576 5/0
TTCGCCGAGAGGGT Cysteine-rich heart protein (CRHP) U09770 5/0
CCGCCCATGAACCC Moesin-ezrin-radixin-like protein L11353 5/0
aH/M values indicate the frequency with which each tag appeared in the pro¢les from HIV (H)- and mock (M)-infected MOLT-4 cells. The fre-
quency of each tags was calculated within a total population of 71 462 tags and 71 147 tags sequenced from HIV-1- and mock-infected MOLT-
4 cells, respectively.
Table 1
Summary of SAGE analysis
HIV Mock Overall
Total number of clones 6 245 6 461 12 706
Total number of tags 71 462 71 147 142 609
Genesa 24 872 24 741 43 581
aIndicates the number of di¡erent genes represented by total SAGE tags analyzed.
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showed that persistent TNF-K activation was correlated with
disease progression in patients infected with HIV-1 [15,16].
Furthermore, TNFs apparently activate HIV-1 replication in
vitro [16]. These data suggest that persistent activation of the
TNF system may play important roles in HIV-1 replication
and virus-induced pathogenesis. MAPKK3 was up-regulated
upon HIV-1 infection. HIV-1 envelope glycoproteins rapidly
activate the MAPK pathway and the binding of nuclear tran-
scription factors (AP-1, NF-UB and C/EBP) and stimulate
expression of cytokine and chemokine genes [17]. These events
may lead to the aberrant expression of in£ammatory genes
and may contribute to HIV-1 replication as well as to dysreg-
ulation of the immune system.
The second group of genes are related to transcriptional
factors and stimulators of HIV-1 transcription. Proteins con-
taining a basic region helix-loop-helix zipper motif have DNA
binding activity and have been predicted to mediate protein-
protein interactions with myc and fos [18]. Since expression of
c-myc is essential for HIV-1 infection in T cells [19], it is
possible that the activation of helix-loop-helix zipper protein
by HIV-1 infection may play a role in viral replication and
apoptosis. Expression of the transcription factor GATA-3 was
also up-regulated upon infection. The GATA-3 gene product
binds speci¢cally to the enhancer elements of TCR genes [20].
GATA3 also binds to six GATA-3 binding sites in the U3
region of the HIV-1 LTR and enhances LTR-mediated tran-
scription activity [21]. The up-regulation of GATA-3 in HIV-
1-infected T cells may lead to induction and augmentation of
HIV-1 replication in addition to its normal role in T cell gene
expression.
4.2. Genes encoding anti-apoptotic proteins are
down-regulated
Our SAGE analysis also revealed a number of genes that
were markedly inhibited by HIV-1, which we subdivided into
four groups.
The ¢rst group included mitochondrial proteins and anti-
oxidants [22]. Indeed, HIV-1 infection is characterized by sig-
ni¢cant impairments of antioxidative defenses [23]. Oxidative
stress has also been proposed to be involved in immunologic
defects as well as in lymphocyte cell death and viral replica-
tion in HIV-1-infected patients [24]. Thiol-containing antiox-
idants have been shown to have bene¢cial e¡ects on CD4 T
lymphocyte survival and to inhibit apoptosis and HIV-1 rep-
lication most probably through blocking the activation of
NF-UB [23]. It is thus possible that a decrease in the levels
of thiol-speci¢c antioxidant upon HIV-1 infection results in
the generation of reactive oxygen species (ROS) and apoptosis
[25]. Down-regulation of cytochrome c oxidase (COX) is also
reported in Mycobacterium tuberculosis infection in macro-
phages [26]. Down-regulation of COXs upon infection with
HIV-1 may result in mitochondrial respiratory insu⁄ciency
Table 3
Down-regulated genes in HIV-1-infected T cells
SAGE tag Gene description Accession number H/Ma
1. Mitochondrial proteins and anti-oxidants
TATACTTCACAACA Mitochondrion cytochrome b U09500 7/50
CCAGTGATCCCCAC Cytochrome c oxidase subunit Vib (COXVib) X54473 1/30
TGTCTCTCTCCTTG ATP synthase L subunit M27132 2/19
CACTGCTAATAAAT Cytochrome c oxidase subunit IV (COX IV) M21575 2/19
ACATAAGTTATTTC ADP/ATP carrier protein J02683 1/17
CAGGAAAGAGGATA Mitochondrial aspartate aminotransferase M22632 0/16
CTGGATGAAGCATA Glutathione S-transferase homolog U90313 2/16
ACAGACGAGCATGG Thiol-speci¢c antioxidant X82321 0/12
TGAGACCTAGAGTC ADP/ATP translocase J03592 0/11
TCCTATGCAATATT ADP-ribosylation factor 1 M84326 1/11
AAACCCACGTTTTG Mitochondrial 75 kDa iron sulfur protein X61100 0/9
TTTGCTCCATTGTT 150 kDa oxygen-regulated protein (ORP150) U65785 0/8
2. Actin-related factors
TGACCTCGTCTGTC Pro¢lin J03191 15/66
TCTGGTGAGTCACC GTP binding protein (rhoC) L25080 2/32
GGGAGTTTCTTGGT Arp2/3 protein complex subunit p34-Arc (ARC34) AF006085 1/7
CATACATGAGTTAT Actin-related protein Arp2 (ARP2) AF006082 0/6
ACAATCATTTAATA Rho GDP-dissociation inhibitor 2 X69549 0/5
3. Translational factors
CCCTGGCCGTGTGT Eukaryotic initiation factor 4AI D13748 7/50
TCCAGAGGAGTGTG Nucleolar protein hNop56 Y12065 2/17
CCAAGTCTTACGTT Inducible poly(A) binding protein U33818 0/10
TGCTTCCAAGCAGC DEAD box protein family X70649 1/8
TCCTGTTTGGAAGT Translation initiation factor nuk34 X79538 0/7
TACGTGAAACTGAA Nuclear RNA helicase Z37166 1/6
ACTTGCTGGTCTAG Translation initiation factor 3 U94855 0/5
4. Miscellaneous genes
CGATCCTGAGACCT Ornithine decarboxylase (ODC1) M16650 2/24
GCAAAGAGAACCAG Cyclin A/CDK2-associated p19 (Skp1) U33760 1/17
TAACTTTCCTTCAT Interleukin 2 receptor (IL2RG) Q chain D11086 2/12
TATAAGTAGTTGGT Prothymosin K M14630 1/12
GTGCTAACAGGCTC Transferrin receptor X01060 1/11
CCTGGGGAATCAAC EST 2 AA825204 1/10
TGTCTGGCTTGGAT RanGTP binding protein 5 Y08890 1/8
TTGGTAAGAGGGAG Down syndrome critical region protein (DSCR1) U28833 0/6
TTCGAATTTGAGTT TGF-L receptor interacting protein 1 U36764 1/5
aConditions are as described in Table 2.
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and general interference with oxidative metabolism leading to
apoptotic cell death [22].
Secondly, some genes relevant to actin polymerization and
related molecules were down-regulated. Polymerization of ac-
tin has been implicated in reverse transcription [27] and direc-
tional budding [28] of HIV-1 from infected cells. Down-regu-
lation of actin-related factors may contribute to a host cell
defense mechanism which blocks virus replication and bud-
ding as well as cellular malfunction accompanied by the dis-
organization of cytoskeleton, cell cycle and adhesion mole-
cules in HIV-1-infected T cells [29].
The third group of genes are those related to cellular trans-
lation [30]. This indicates that HIV-1 infection directly causes
the breakdown of cellular replication systems and it might
therefore be involved in T cell depletion.
This is the ¢rst report that demonstrates the systematic
pattern of gene expression in HIV-infected cells by SAGE
analysis. To provide a simpli¢ed picture of changes in gene
expression with HIV infection by SAGE, the present study
used a monoclonal T cell line and a monoclonal HIV strain
(HIV-1NL4ÿ3), and therefore the results are only preliminary.
Further studies using other samples such as those from HIV-
1-infected individuals at various stages of infection are neces-
sary.
In summary, we have shown that at least 53 cellular genes
are up- or down-regulated in HIV-1-infected T cell lines by
SAGE analysis. Further study of the genes identi¢ed in this
study should provide new and useful insights into virus-host
cell interactions, the pathogenesis of and potential treatments
for HIV-1 infection.
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